FDA approves Dovato for teens living with HIV retrieved 11 April 2024 from https://medicalxpress.com/news/2024-04-fda-dovato-teens-hiv.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.5 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Long-acting injectable ART superior to standard care for poorly adherent people with HIVFor people with HIV (PWH) and a history of suboptimal adherence to antiretroviral therapy, long-acting injectable treatment with cabotegravir and rilpivirine (LAI) is superior to oral standard of care (SOC), according to a study presented at the annual Conference on Retroviruses and Opportunistic Infections, held from March 3 to 6 in Denver.
Source: medical_xpress - 🏆 101. / 51 Read more »
Alligator Blood Antibiotic Could Kill Strains of E.coli, HIVResearchers find proteins that could be instrumental in fighting serious diseases
Source: NECN - 🏆 20. / 71 Read more »
Drug candidate may 'unmask' latent HIV-infected cells, mark them for destructionUniversity of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.
Source: medical_xpress - 🏆 101. / 51 Read more »
FDA approves first CAR T-cell therapy for adults with leukemia or lymphomaThe U.S. Food and Drug Administration has approved Bristol Myers Squibb's Breyanzi (lisocabtagene maraleucel [liso-cel]) as the first CD19-directed chimeric antigen receptor (CAR) T-cell therapy for adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL).
Source: medical_xpress - 🏆 101. / 51 Read more »
New drug candidates show promise to reverse HIV immune evasionUniversity of Pittsburgh School of Medicine scientists have identified drug candidates that show promise to reverse the ability of HIV to escape detection by the immune system.
Source: NewsMedical - 🏆 19. / 71 Read more »
HIV cure breakthrough as scientists find way of eliminating AIDS-causing virusUsing 'genetic scissors', researchers at Amsterdam UMC, the Netherlands, were able to snip out the virus from infected T cells in the laboratory, removing all traces.
Source: DailyMailUK - 🏆 7. / 90 Read more »